n-Lorem Foundation
@n_lorem
Non-profit discovering, developing, and providing personalized experimental ASO medicines to treat nano-rare patients — for free, for life
📬 Our 2025 Annual Letter is here! Read ➡️ nlorem.org/our-approach/c…

Extracting RNA like it’s liquid gold—because in this lab, it is 🪙

Great to be at the inaugural ReNU Hope Conference and Scientific Symposium! n-Lorem featured two presentations and a scientific poster highlighting our ReNU research efforts.

Art by Emmery, who lives with KIF1A-Associated Neurological Disorder. Like a wave, she rises again and again. 💙💜

Meet Emmery 💜 An n-Lorem patient from Alabama living with KIF1A Associated Neurological Disorder (KAND). Her mom, Valerie, recently shared their story on @whnt whnt.com/news/madison/o…
Why are we making custom drugs for free? Because no one else will.
@ionispharma and @n_lorem Founder Stanley Crooke joins to discuss the fight against rare diseases with his new foundation, that treats patients for free, for life. cnb.cx/46k8OJZ
The 2025 Nano-rare Patient Colloquium Agenda is here! 🧬 Get ready to be informed, inspired, and connected. The nano-rare community is coming together—don’t miss it! ✅ Register to join us in-person or virtually 🎤 Explore the speaker lineup and bios nlorem.org/nano-rare-pati…




No @MLB games today? We've got you covered. While your favorite team rests, check out this incredible painting by Mostyn—a young fan living with a nano-rare KCNB1 mutation—who finds comfort in baseball on even the hardest days ⚾🧬

We’re proud to welcome ChemGenes as a gold sponsor of the 2025 Nano-rare Patient Colloquium! As a trusted partner, ChemGenes supports n-Lorem by manufacturing ASO drug substances in a range of batch sizes, from non-GMP to GMP standards. Register: nlorem.org/nano-rare-pati…

Retweet if you believe every life—no matter how rare the mutation—is worth fighting for.